Advertisement
Advertisement
AVTX
Avalo Therapeutics, Inc. Common Stock
6.93
USDSponsored
+0.30
+4.52%
Nov 06, 15:59 UTC -5
Closed
After-Market
6.95
+0.02
+0.22%
Avalo Therapeutics, Inc. Common Stock (AVTX)
Avalo Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 401.58M |
| Beta | 0.75 |
| Earnings Per Share (EPS) | -2.52 |
| Price-to-Book (P/B) Ratio | 0.82 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -44.32% |
| Current Ratio | 16.63% |
| Free Cash Flow | -49.22M |
